These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Prophylaxis of recurrence in superficial bladder carcinoma by intravesical chemotherapy--comparative study between instillation of combined double anticancer agents and single anticancer agent].
    Author: Ikeda R, Chikazawa I, Kobayashi Y, Shiroma K, Nakade T, Suga K, Shiba N, Nakajima C, Moriyama M, Kawamura K, Miyazawa K, Tanaka T, Tsugawa R, Suzuki K, Sato H, Kikuyama A.
    Journal: Gan To Kagaku Ryoho; 1999 Mar; 26(4):509-14. PubMed ID: 10097748.
    Abstract:
    We performed a study to compare the usefulness of double or single anticancer agents in the prophylactic treatment after the transurethral resection (TUR) of superficial bladder cancer. We experienced 127 superficial bladder cancer cases. Of these cases, 42 were treated with intravesical adriamycin (ADR) and peplomycin (PEP), 56 with ADR, PEP, epirubicin (epi-ADR) or pirarubicin (THP) only, and the remaining 29 with TUR only. Nonrecurrence rates were significantly higher in the intravesical treated cases than in the cases with TUR only, and also significantly higher in the cases treated with ADR and PEP than the other treated cases. We concluded that intravesical chemotherapy with combined agents was more effective than with a single agent.
    [Abstract] [Full Text] [Related] [New Search]